AMGEN INC 2012-13.9.29 REG-S SENIORAMGEN INC 2012-13.9.29 REG-S SENIORAMGEN INC 2012-13.9.29 REG-S SENIOR

AMGEN INC 2012-13.9.29 REG-S SENIOR

No trades
See on Supercharts

AMGC analysis



Key facts


Issue date
Sep 13, 2012
Maturity date
Sep 13, 2029
Outstanding amount
‪700.00 M‬GBP
Face value
1,000.00GBP
Minimum denomination
100,000.00GBP
Coupon
4.00% (Fixed)
Yield to maturity
4.93%
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.
Go deeper with bond data
Access the most important data for bonds including coupon rates, issue ratings, redemption data and more.